AI-powered clinical trial operations and patient recruitment platform
Iterative Health combines clinical research expertise with AI to accelerate trial enrollment and sponsor operations. The tech stack reveals dual infrastructure priorities: clinical/healthcare systems (EHR, HL7, FHIR, HealthStream) paired with modern data pipelines (Snowflake, BigQuery, Python) and business intelligence (Power BI, Looker, Tableau), enabling real-time trial metrics and forecasting. Active hiring spans research (16 roles), sales (8), and data (2), with 41 open positions posted in the last 30 days—the research-heavy mix and leadership gap in compliance suggest rapid scaling of clinical operations and regulatory infrastructure.
Notable leadership hires: Compliance Director
Iterative Health is a healthcare technology and services company operating at the intersection of clinical research and AI-driven operations. The company works with research teams and pharmaceutical sponsors to improve trial enrollment, site performance, and path-to-market speed for novel therapeutics. Core operations include trial enrollment forecasting, capacity modeling, sponsor account management, and a growing biological specimen collections business. Headquartered in Cambridge, Massachusetts with operations in New York, the company serves the pharmaceutical and biotechnology sectors and employs 51–200 people across research, sales, operations, and data functions.
Clinical systems (EHR, HL7, FHIR, HealthStream), data platforms (Snowflake, BigQuery, Redshift, Python), BI tools (Power BI, Looker, Tableau), and business ops (Salesforce, HubSpot, NetSuite, Workday, Rippling).
Cambridge, Massachusetts, with an additional office in New York. Founded in 2017, the company is privately held and employs 51–200 people.
Iterative Health's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.